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Comparative eﬀects of red and white grapes on
oxidative markers and lipidemic parameters in
adult hypercholesterolemic humans
Ali Reza Rahbar,*a Mohammad Mehdi Shakouri Mahmoudabadia and
Md. Shahidul Islamb
The present study compared the eﬀects of consuming red versus white whole grapes on oxidative and
lipidemic indices in people with hypercholesterolemia. Sixty nine patients were randomized into three
groups. The two treatment groups consumed 500 g of either Condori red grapes or Shahroodi white
grapes daily for 8 weeks, and the third group served as a control. Plasma glucose, triacylglycerol (TG),
cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C),
thiobarbituric acid reactive substances (TBARS) and total antioxidant capacity (TAC) were determined by
colorimetric methods at baseline and at the end of the study. In addition, the polyphenol and ﬁber
content of the two grape varieties was measured. TBARS was reduced in both study groups compared to
the control group, and the reduction was greater in the group that consumed red grapes compared to
the white grapes. TAC was increased signiﬁcantly in both red and white grape consuming groups com-
pared to the control group. Total cholesterol and LDL-C were decreased in the red grape group com-
pared to the control group. No signiﬁcant changes in fasting blood glucose, TG or HDL-C were observed
among the groups. The results of this study suggest that consumption of the whole fruit of red grapes has
more potent anti-oxidative and hypolipidemic eﬀects compared to the white grapes in hyperlipidemic
adult humans. Hence, the whole fruit of red grapes may be an excellent fruit choice not only to prevent
oxidative stress related metabolic disorders but also cholesterol related cardiovascular diseases, particu-
larly in hyperlipidemic adult humans.
1. Introduction
Cardiovascular diseases (CVD) are the major threat to global
public health and the leading cause of mortality among
patients with chronic non-communicable diseases. Elevated
serum total cholesterol, low-density lipoprotein cholesterol
(LDL-C) and triglycerides (TG) have been recognized as the
major risk factors for cardiovascular and coronary heart dis-
eases.1 Furthermore, the oxidative modification of LDL-C has
been found to be a critical event in triggering the development
of atherosclerosis.2 The “Mediterranean” dietary pattern has
been found as one of the most eﬀective types of protection
against CVD along with the consumption of adequate
amounts of fruits and vegetables.3 In some previous studies,
although the cardio-protective properties of fruits and vege-
tables were attributed to their high level of fiber4 and
phytochemicals,5–9 extensive epidemiological evidence
suggests that the dietary intake of fiber along with phytochem-
icals reduces the cardiovascular mortality by modulating oxi-
dative status and ameliorating dyslipidemia.10,11
Epidemiological data from World Health Organization
(WHO) revealed the discrepancies in cardiovascular mortality
among cohorts from 17 western countries compared to a
cohort of subjects from Toulouse, France.12,13 This counterin-
tuitive finding, termed “French paradox”, stimulated further
research that led to several possible explanations for this dis-
cordance. We hypothesized that the increased consumption of
grapes (Vitis vinifera) and grape products in Mediterranean
countries might be one of the reasons for lower death from
CVD.
Evidence recovered 6000 years ago from archaeological
investigations in Egypt has indicated the medicinal value of
grapes.14 This fruit contains a wide variety of polyphenolic
compounds, including flavonoids and non-flavonoid agents
with cardio-protective properties.15 The concentrations of
these compounds are varied based on the variety of grapes,
climate and light, ripeness, processing and storage
conditions.16
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Several types of grapes have been studied, but some
research indicated that darker varieties are more beneficial for
humans due to their higher content of phytochemicals.17
White grape varieties and their cardio-protective eﬀects have
not been well studied compared to the darker cultivars.18 To
the best of our knowledge, there is no clinical trial in humans
which compared the eﬀect of white grape versus red grape culti-
vars on lipidemic and oxidative markers. In this study, we evalu-
ated the eﬀect of consuming two Iranian grape cultivars, e.g.
Condori red grapes and Shahroodi white grapes, on oxidative
markers and lipidemic parameters in hypercholesterolemic sub-
jects. Since polyphenols are mainly distributed in grape skins,
stems, leaves and seeds rather than in the juicy pulp,19 the prin-
cipal aim of this study was to examine and compare the eﬀects
of whole fresh red and white grapes including the seeds and
skin on lipidemic and oxidative markers in hypercholesterole-
mic adult humans. We also analyzed the total polyphenol and
fiber content of these two cultivars of grapes.
2. Materials and methods
2.1 Human subjects and experimental design
One hundred patients with hypercholesterolemia (30 men and
70 women, mean age 52.6 years) have been selected from the
outpatient department of the Shohada hospital in Tehran, Iran,
based on their medical records. A written consent was taken
from all patients regarding their participation in this study.
First of all, all agreed patients were invited to attend a seminar
where the consequences of dyslipidemia and its relationship to
CVD were explained along with the objectives of the study.
The inclusion and exclusion criteria of patients in this
study are shown in Table 1. Out of 100 individuals, 69 satisfied
the entry criteria and completed the study. Based on the
results of a previous study,20 the required sample size for our
interventional trial with an 8-week follow-up period was calcu-
lated by using a G-Power software (version 3.1, Informer
Technologies, Inc.) since the mean change in cholesterol after
grape consumption was achieved after this period of time.
The experimental protocol of the trial was approved by the
Shohada Hospital Review Board (DP/8703277/176, 14/5/2008).
The ethical aspects of the study were also approved by the
Ethics Committee of Shahid Beheshti University of Medical
Sciences in May 2008 (Ethical approval no. 18525). The entire
study was carried out in accordance with the principles of the
Helsinki Declaration as revised in 2000. The participants were
instructed not to take any antioxidant supplements from 8
weeks before the study.
2.2 Intervention
Baseline measurements were collected for a 3-week period
when all participants consumed their usual diet. They were
randomly assigned to one of the 3 groups after stratification by
sex, age and body mass index. The participants in group 1
received 500 g of Condori red grapes and those in group 2
received 500 g of Shahroodi white grapes daily in 5 servings of
100 g each for 8 weeks intervention period. The group 3 or
control group was used for the stratification of changes in
dietary intake or fluctuations in serum lipids related to the
summer season when this group similarly consumed 5 ser-
vings of other fruits except grapes.21 The grapes were pur-
chased from Ghazvin province orchards, Ghazvin, Iran, in
which polyphenol and fiber concentrations have been analyzed
(Fig. 1).
Participants were instructed not to change their level of
physical activity or other lifestyle factors throughout the inter-
vention period. Before the baseline period, written and verbal
instructions were provided to the participants by a dietician on
how to keep accurate dietary records, including how to weigh
or measure foods. A 3-day dietary record (2 weekdays and








BMI (kg m−2) >19.8 but
<35
Medicine Use of anti-inflammatory, lipid-
lowering, beta-adrenergic
antagonist, and thiazide diuretic
medications
Diseases Previous medical history of
diabetes, thyroid, liver, renal and
chronic inflammatory diseases
(plasma creatinine >1.47 mg dl−1),
heart disease, angina, or major
surgery; had a recent history
(within 6 months) of myocardial
infarction or stroke.
Diet Special diet
Supplements Fish oil or omega-3, vitamin E, C,
selenium, lipoic acid supplements
Fig. 1 Average of the total polyphenol and ﬁbre content of grapes per
gram dried matter: the polyphenol content in the red grape cultivar was
signiﬁcantly higher than the white grape cultivar (0.652 ± 0.23 vs. 0.598 ±
0.18 mg g−1). The ﬁber content of the white grape cultivar was signiﬁ-
cantly higher than the red grape cultivar (54 ± 2.3 vs. 28 ± 1.9 mg g−1).
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1 weekend day) and a lifestyle related questionnaire including
history of illness, medications and physical activity were com-
pleted at baseline and after the intervention period. Physical
activities of participants were evaluated by an Epic-Norfolk
Physical Activity Questionnaire. Energy consumption from
each food, beverage and other nutrients was analyzed by
NUTRITIONIST III software (version 7.0; N-Squared Comput-
ing, Salem, OR, USA), which was designed for Iranian foods.
The body weight and height of all participants were
measured with a digital scale and non-stretchable measuring
tape. Body weight, changes in physical activity, medication,
and any illnesses were recorded weekly during baseline and at
weeks 2, 4, 6 and at the end of the intervention period.
2.3 Biochemical measurements
Fasting blood samples were taken at baseline and at the end of
the 8-week intervention period. All samples were promptly cen-
trifuged at 3000g for 15 min at 4 °C. Immediately after cen-
trifugation the plasma samples were separated and analyses
were carried out with a Selectra 2 Auto Analyzer (Vital Scienti-
fic, Spankeren, The Netherlands). Plasma glucose was deter-
mined with a glucose analyzer (YSI, Yellow Springs, OH).
Serum TG was measured with glycerol-3 phosphate oxidase
phenol aminoantipyrine in an automated Technicon Axon
Analyzer. Total HDL-C levels (after precipitation with mag-
nesium chloride) were measured with enzymatic techniques
(Pars Azmun, Tehran, Iran). The LDL-C level was calculated
with the Friedewald formula22 as follows:
LDL-cholesterol ¼ ½Total cholesterol ðHDL-cholesterol
þ TG=5Þ
where, TG/5 is equivalent to the concentration of VLDL-
cholesterol.
The total plasma antioxidant capacity (TAC) was determined
by the generation of colored 2,2′-azinobis-(3-ethylbenzothiazo-
line-6-sulfonic acid radical cation method) (Randox Inc.
Antrium, Northern Ireland, UK).23
The lipid peroxidation rate as a marker of oxidation was
estimated by measuring thiobarbituric acid reactive substances
(TBARS), and was reported as the malondialdehyde equivalent
(MDAE).24
2.4 Samples for fiber and polyphenol measurements
All samples of grapes were harvested from vines grown in
Ghazvin province, Iran. The red and white grape orchards were
divided into six equal areas and 100 berries were collected
from each area. Grape berries were placed in polyethylene bags
and transported under refrigerated conditions to the Faculty of
Nutrition, Department of Biochemistry, Shahid Beheshti
Medical University, Tehran, Iran. The aqueous extract of each
sample of grape berries was obtained by boiling the dried part
of grapes for 30 min in distilled water at a ratio of 1 : 100 (w/v),
and incubated overnight at 40 °C with slow shaking on an
orbital shaker (Stuart Scientific Orbital Shaker, Staﬀordshire,
UK). The water-soluble fraction was centrifuged at 6000g for
10 min and the insoluble precipitate was discarded. The super-
natant was filtered with Whatman no. 1 filter paper. The fil-
trate was concentrated under reduced pressure at 40 °C with a
rotary evaporator (Laborota 4000, Heidolph, Germany) and
finally freeze-dried to obtain the grape extract. The resulting
sample was powdered and sealed in a plastic bag for sub-
sequent use.
2.5 Measurement of polyphenols
The amount of total polyphenols in the grape extract was
determined with a modified pharmacopeia colorimetric
method.25 The freeze-dried extract was dissolved in an
ammonium chloride and methanol mixture (20 mg mL−1) and
further dilutions were done to obtain readings within the stan-
dard solution curve at diﬀerent concentrations of 24, 32, 48,
56, 64 µg mL−1. The samples were kept in the dark for 40 min
and absorbance was then read at 415 nm. The results were
expressed as milligrams of polyphenol per gram of the dried
extract.
2.6 Measurement of fiber
The total fiber content of the grapes was determined by
measuring the parts of defatted grapes remaining after boiling
with sulfuric acid and sodium hydroxide, with methods
approved by the American Association of Cereal Chemists.26
2.7 Statistical analysis
The distribution of variables was studied with probability plots
and the Shapiro–Wilks test. Baseline demographic and bio-
chemical values were compared between the groups with one-
way ANOVA. Bonferroni correction was used wherever there
was a major eﬀect. The diﬀerences between the groups in
serum TBARS, TAC and serum glycemic and lipidemic para-
meters were analyzed by one way ANOVA, with an adjustment
for age, body weight and sex. Unpaired t-tests were used wher-
ever there was a major eﬀect.
Paired t-tests were used to compare variables within groups.
The Man–Whitney U test was used to determine diﬀerences
between groups in the polyphenol and fiber content. A value of
p < 0.05 was accepted as significant. All statistical analyses
were done with an IBM computer using the SPSS 18 statistical
software package (SPSS Inc., Chicago, IL, USA).
Sample size was estimated by the F test with G-Power stat-
istical software, version 3.1, based on a two-sided type I error
of 5% and 84.5% power. The significance level was set at
p < 0.05.
3. Results
Out of 100 participants screened, 69 satisfied the entry criteria
and completed the study. The characteristics of the patients
confirmed that the groups were well matched for all entry cri-
teria (Table 2). There were no significant diﬀerences between
the groups in total energy intake, micro- and macronutrient
intake or body weight at baseline. Physical activity was
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unchanged during the intervention in all groups (data not
shown).
After an 8-week intervention period, the concentrations of
TBARS were decreased by 23% (p < 0.001) and 6% (p = 0.02) in
Condori red and Shahroodi white grape consuming groups,
respectively (Table 3). Analysis of covariance between groups
showed a significantly higher reduction in TBARS in the red
grape group than in the white grape and control groups
(Table 4). The total antioxidant capacity (TAC) was significantly
increased (p < 0.001) in the red grape and white grape groups
(Table 3) compared to the baseline data (Table 2). The induc-
tion of TAC was significantly higher in the red grape and white
grape groups compared to the control group (p < 0.001), when
no significant diﬀerence was found between the red grape and
white grape consuming groups (Table 4).
At the end of the study, the total cholesterol concentration
was 9% (p = 0.001) and 8% lower (p = 0.005) in the red grape
and white grape consuming groups respectively compared to
Table 2 Baseline characteristics of the participants (n = 69). Means ± SDa
Characteristic Red grape White grape Control P value
Number 22 24 23 NS
Male 4 6 4 NS
Female 18 18 19 NS
Age (years) 50.5 ± 10.6 50.6 ± 9.0 52.5 ± 11.5 NS
Weight (kg) 71.4 ± 14.4 72.3 ± 16.2 69.0 ± 10.7 NS
BMI (kg m−2) 27.5 ± 7.5 28.5 ± 5.2 27.8 ± 4.1 NS
Biochemical markers
TBARS (MDAE, µmol L−1) 2.15 ± 0.01 2.12 ± 0.02 2.17 ± 0.01 NS
TAC (mmol L−1) 1.51 ± 0.01 1.51 ± 0.02 1.60 ± 0.01 NS
FBG (mg dL−1) 84.60 ± 10.23 86.45 ± 12.35 89.31 ± 13.22 NS
Cholesterol (mg dL−1) 242.61 ± 4.97 230.45 ± 30.54 231.57 ± 27.03 NS
LDL-C (mg dL−1) 164.90 ± 20.92 147.22 ± 37.68 149.02 ± 29.10 NS
HDL-C (mg dL−1) 44.54 ± 7.91 46.72 ± 11.52 39.07 ± 8.24 0.01
TG (mg dL−1) 180.09 ± 72.48 182.95 ± 103.83 209.77 ± 87.93 NS
Dietary intake
Energy (calories) 1741 ± 341 1698 ± 502 1471 ± 411 0.09
Total fat (g per day) 53.20 ± 12.60 52.09 ± 18.88 50.20 ± 23.54 NS
SFA (g per day) 16.33 ± 4.36 16.55 ± 6.76 17.05 ± 11.90 NS
MUFA (g per day) 17.89 ± 5.65 16.99 ± 7.98 16.90 ± 8.43 NS
PUFA (g per day) 14.02 ± 5.10 14.07 ± 4.72 12.29 ± 5.68 NS
Cholesterol (mg per day) 169.17 ± 90.97 178.30 ± 119.25 173.70 ± 89.14 NS
Carbohydrate (g per day) 266.66 ± 66.95 264.29 ± 77.17 214.04 ± 56.67 NS
Vitamin C (mg per day) 120.49 ± 79.99 113.60 ± 68.23 115.14 ± 65.48 NS
Vitamin E (mg per day) 11.45 ± 6.12 11.45 ± 5.19 10.46 ± 4.46 NS
Selenium (mg per day) 75.42 ± 23.08 78.31 ± 20.30 77.2136 ± 21.41 NS
aNo significant diﬀerences were found between groups in baseline variables except for HDL-C. BMI = Body mass index; TBARS = Thiobarbituric
acid reactive substances, MDAE = Malondialdehyde equivalent; TAC = Total antioxidant capacity; FBG = Fasting blood glucose; LDL-C = Low
density lipoprotein cholesterol; HDL-C = High density lipoprotein cholesterol; TG = Triacylglycerol; SFA = Saturated fatty acids MUFA =
Monounsaturated fatty acids; PUFA = Polyunsaturated fatty acids.
Table 3 Changes in each group after the dietary interventiona
Serum parameters
Red grapes White grapes Control group
Before After Before After Before After
TBARS (MDAE, μmol L−1) 2.15 ± 0.01 1.65 ± 0.05* 2.12 ± 0.02 1.99 ± 0.02# 2.17 ± 0.01 2.09 ± 0.01*
TAC (mmol L−1) 1.51 ± 0.01 1.56 ± 0.02* 1.51 ± 0.01 1.56 ± 0.02* 1.60 ± 0.13 1.57 ± 0.03*
FBG (mg dL−1) 84.60 ± 10.23 84.681 ± 7.99 86.454 ± 12.35 92.568 ± 12.49 89.310 ± 13.22 87.00 ± 12.48
Chol. (mg dL−1) 242.61 ± 4.97 220.857 ± 7.209* 230.45 ± 30.54 211.40 ± 33.73* 231.57 ± 27.03 228.71 ± 28.72
LDL-C (mg dL−1) 164.90 ± 20.92 140.613 ± 32.365* 147.227 ± 37.68 132.95 ± 35.43# 149.02 ± 29.10 153.20 ± 28.04
HDL-C (mg dL−1) 44.54 ± 7.91 41.72 ± 9.40 46.72 ± 11.52 43.42 ± 10.54 39.07 ± 8.24 36.53 ± 8.10
TG (mg dL−1) 180.09 ± 72.48 178.90 ± 90.18 182.95 ± 103.83 175.13 ± 94.38 209.77 ± 87.93 198.95 ± 69.86
a All data are presented as mean ± SD. *Significantly diﬀerent from baseline (by paired t-test): p < 0.01. #Significantly diﬀerent from baseline (by
paired t-test): p < 0.05. MDAE = malondialdehyde equivalent; TBARS = thiobarbituric acid reactive substances; TAC2008 = total antioxidant
capacity; FBG = fasting blood glucose; Chol. = cholesterol; LDL-C = low density lipoprotein cholesterol; HDL-C = high density lipoprotein
cholesterol; TG = triacylglycerol.
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the baseline (Table 3). The reduction of total cholesterol was
significant (p = 0.04) in the red grape group but not in the
white grape group compared to the control group (Table 4).
The level of LDL-C was 14% lower (p = 0.001) in the red
grape group and 10% lower (p = 0.04) in the white grape group
after the intervention (Table 3) when the reduction was signifi-
cant only for the red grape group compared to the control
group (p = 0.01) (Table 4).
No significant changes in fasting blood glucose, TG or
HDL-C were observed within or between the groups after the
intervention (Table 3). No significant changes in dietary
energy, total fat, cholesterol, saturated fatty acids, monounsa-
turated fatty acids, polyunsaturated fatty acids, carbohydrates,
vitamin C, vitamin E and selenium content were observed
between the groups during this study (Table 4).
4. Discussion
The principal aim of the present study was to examine and
compare the eﬀects of whole fresh red and white grapes
including the seeds and skin on lipidemic and oxidative
markers in hypercholesterolemic adult humans. A number of
previous studies reported that the total polyphenol content of
fruits and vegetables is closely linked with the lower lipid per-
oxidation and higher TAC. Although a higher amount of poly-
phenols such as 800 mg27 and 1400 mg28 were supplied per
day in order to achieve significant eﬀects on cardiovascular
disease related biomarkers in humans, according to a recent
meta-analysis, 5 servings of fruits and vegetables (5 × 100 g =
500 g) in the Mediterranean diet have been found as one of
the major indicators for the reduction of cardiovascular and
cerebrovascular risks.29 Hence, in our study, 500 g of grapes
were supplied in 5 servings as 100 g per serving per day.
Although the amount of polyphenol received from 500 g of
grapes per day in our study was significantly lower (312 mg)
than the above-mentioned studies,27,28 the antioxidative as
well as the hypolipidemic eﬀect of polyphenols may be
diﬀerent among the grape varieties due to their diﬀerent com-
positions of polyphenols. In a recent study, Anastasiadi et al.30
reported that the total polyphenol content as well as the anti-
oxidative properties of the Mandilaria red grape cultivar are
significantly higher than the Aidani white grape cultivar.30 In
addition, several studies have reported significant reduction in
TBARS after the administration of the seeds,10 skins11 and the
pulp of whole red grapes31 in human and animal models.
However, few studies have investigated the eﬀect of white
grape cultivars on TBARS and no study compared the eﬀects of
whole red and white grape consumption either in humans or
in experimental animals. The results of the present study
showed a significantly higher reduction in serum TBARS con-
centration in individuals who consumed red grapes compared
to those who consumed white grapes and the control group
(Tables 3 and 4). Serum TAC also increased after red grape con-
sumption, although the value after the intervention period did
not diﬀer significantly between the two treatment groups.
These results indicate robust antioxidant properties of red
grapes compared to the white grapes. The significantly higher
total polyphenol content in the red grape cultivar than the
white grape cultivar might be the reason for lower serum
Table 4 Diﬀerences between groups after the dietary interventiona
Group/characteristics Red grape White grape Control
TBARS (MDAE, μmol L−1) −0.50 ± 0.051#* −0.13 ± 0.0001* −0.07 ± 0.01
TAC (mmol L−1) 0.04 ± 0.02* 0.05 ± 0.007* −0.02 ± 0.03
FBG (mg dL−1) .0773 ± 9.97 6.11 ± 15.54 −2.31 ± 13.44
TG (mg dL−1) −1.18 ± 53.73 −7.81 ± 53.28 −10.82 ± 69.17
Cholesterol (mg dL−1) −24.22 ± 29.95* −19.04 ± 28.46 −2.85 ± 28.00
LDL-C (mg dL−1) −24.29 ± 28.42* −14.27 ± 31.32 4.18 ± 33.90
HDL-C (mg dL−1) −2.81 ± 7.35 −3.30 ± 10.87 −2.54 ± 6.26
Dietary intake
Energy (calories) −28.76 ± 542.9 −7.00 ± 408.39 124.04 ± 395.6
Carbohydrate (g per day) −15.90 ± 91.06 −12.16 ± 65.69 0.86 ± 69.82
Total fat (g per day) 5.30 ± 21.42 5.23 ± 19.10 6.97 ± 21.86
Cholesterol (mg per day) 81.58 ± 112.38 73.82 ± 145.80 56.20 ± 99.03
SFA (g per day) 1.63 ± 7.07 2.24 ± 9.49 1.45 ± 11.23
MUFA (g per day) 2.61 ± 11.20 2.71 ± 8.53 3.18 ± 7.79
PUFA (g per day) 1.13 ± 7.32 2.00 ± 8.29 1.30 ± 6.04
Vitamin C (mg per day) −44.73 ± 108.45 −25.26 ± 83.39 −66.56 ± 123.14
Vitamin E (mg per day) 0.91 ± 4.92 0.03 ± 9.15 −0.58 ± 7.05
Selenium (mg per day) −23.73 ± 39.71 26.81 ± 59.16 −20.89 ± 197.87
aData are presented as mean ± SD. One-way ANOVA was used to assess the treatment eﬀects between the groups. Unpaired t-test was used to
compare the significant eﬀect between two groups. *Significantly diﬀerent in each of the two treatment groups compared to the control group
p < 0.05). #Significantly diﬀerent for the red grape group compared to the white grape group (p < 0.05). MDAE = malondialdehyde equivalent;
TBARS = thiobarbituric acid reactive substances; TAC = total antioxidant capacity; FBG = fasting blood glucose; TG = triacylglycerol; LDL-C = low
density lipoprotein cholesterol; HDL-C = high density lipoprotein cholesterol; SFA = saturated fatty acids; MUFA = monounsaturated fatty acids;
PUFA = polyunsaturated fatty acids.
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TBARS concentration and higher TAC in the red compared to
the white grape consuming group.
The diﬀerences in the anti-oxidative characteristics of
Condori red grapes and Shahroodi white grapes are also likely
related to diﬀerences in the chemical compositions of the two
cultivars, particularly with regard to polyphenols. The most
obvious diﬀerence between these cultivars is the color of the
berries, which reflects the presence of diﬀerent types of poly-
phenolic compounds. It has been reported that white grapes
are evolutionarily derived from red varieties as a result of
mutations in two regulatory genes and deactivation of the pro-
duction of anthocyanins, which are responsible for the dark
color of red grapes.32 Some studies found at least 25 times
more anthocyanins in red grapes than in white grapes.33
Among fruit pigments, anthocyanins have been recognized as
a potent antioxidant polyphenol. In this connection, serum
anthocyanin concentration is directly related to the serum
total antioxidant capacity. Mazza et al.34 and Choi et al.35 have
suggested that anthocyanins likely play an important role in
the activation of NADPH oxidase, which leads to an increase in
circulating TAC.34,35 Delphinidin, the major subset of antho-
cyanins in dark grapes, has been reported to exert an anti-
atherosclerotic action by protecting vascular endothelial cells
against oxidized LDL-induced endothelial dysfunction.36
According to the results of the above-mentioned studies, some
of these mechanisms might be involved in showing lower lipid
peroxidation (TBARS) and higher TAC of red grapes compared
to the white grapes in our study.
On the other hand, the β-carotene content of white grapes
is responsible for their bright color.37 Several studies have
reported a pro-oxidant role of β-carotene in humans.38–40
Rozenberg et al.40 found that white grape consumption by
mice made them diabetic and resulted in a 22% increase in
macrophage total peroxide levels and a 45% decrease in the
cellular glutathione content.40 Consequently, the lack of antho-
cyanins accompanied by an augmented β-carotene content in
white grapes might be another reason for the lower antioxi-
dant capacity compared to the red varieties which has been
further proved by the eﬀects of grapes on some other para-
meters such as serum lipid profile.
It has been reported that the consumption of raisins
(red variety), which contain ample amounts of dietary fiber4
and polyphenols,41 lowered LDL-C in patients with hyper-
cholesterolemia. It has also been reported that grape fiber
interferes with entero-hepatic bile circulation, which results in
increased bile acid excretion.42 In addition, polyphenols inter-
fere with cholesterol synthesis via microsomal transport
protein inhibition, which is responsible for lipid transfer to
Apo B, and its inhibition increases the susceptibility of Apo B
to degradation and consequently decreases the section of very
low density lipoprotein and circulating LDL-C.43–46 Zern
et al.46 also concluded that grape polyphenols, like fiber, can
interfere with cholesterol absorption.46 Therefore, despite the
high fiber content of Shahroodi white grapes, their low poly-
phenol content is likely to be responsible for the null eﬀect on
serum cholesterol levels compared to the control group. In
contrast, significantly lower serum total cholesterol as well as
LDL-C in the red grape consuming group compared to white
grape consuming and control groups (Table 4) might be due to
the higher polyphenol content.
In the present study, we instructed the participants to
consume whole grape berries, including the seeds. A meta-ana-
lysis of nine randomized controlled trials (N = 390) on the
lipid-lowering eﬀect of the grape seed extract in humans failed
to find significant results,47 whereas studies of the eﬀect of
whole grape berries on lipidemic parameters reported signifi-
cant outcomes.20 There is a consensus that the hypolipidemic
eﬀect of grapes may be the result of the synergic eﬀects of
several compounds rather than a single compound.48 A poten-
tial strength of the present study over previous studies was that
grape berries (both red and white) were consumed as a whole
fruit including the seeds and skin. It was emphasized that the
seeds should be chewed well before swallowing. This made it
possible to investigate the synergic eﬀects of several com-
pounds found in diﬀerent parts of grapes on lipidemic and
oxidative markers. Grape seeds contain high levels of phyto-
sterols and tocopherols (vitamin E), polyunsaturated fatty
acids such as linoleic acid, oleic acid and alpha-linolenic acid,
which are assumed to enhance the anti-oxidative and hypo-
lipidemic properties of grapes.49
5. Conclusion
The results of this study suggest that consumption of the
whole fruit of Condori red grapes has more potent anti-oxi-
dative and hypo-lipidemic eﬀects compared to the whole fruit
of Shahroodi white grapes in hyperlipidemic adult humans.
Hence, the whole fruit of Condori red grapes may be an excel-
lent fruit choice not only to prevent oxidative stress related
metabolic disorders but also to prevent cholesterol related
cardiovascular diseases, particularly in hyperlipidemic adult
humans.
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